Physical activity and nutrition attitudes in obese Hispanic children with non-alcoholic steatohepatitis

Lana N Hattar1, Theresa A Wilson, Leanel A Tabotabo

  • 1Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Baylor College of Medicine, Houston, TX 77030, United States. lhattar@yahoo.com

Insights

Obese children with non-alcoholic steatohepatitis (NASH) exhibit more sedentary behavior and less physical activity and fruit intake compared to peers. These findings highlight potential targets for NASH treatment in pediatric populations.

Area of Science:

  • Pediatric Gastroenterology
  • Hepatology
  • Nutrition Science

Background:

  • Non-alcoholic steatohepatitis (NASH) is increasingly diagnosed in obese children.
  • Lifestyle factors including nutrition and physical activity are implicated in NASH development and progression.
  • Understanding these behaviors in pediatric NASH is crucial for effective management.

Purpose of the Study:

  • To compare nutrition, physical activity, and health knowledge in obese children with biopsy-proven NASH versus obese and lean children without liver disease.
  • To identify specific lifestyle factors associated with NASH in the pediatric population.

Main Methods:

  • A case-control study comparing biopsy-proven NASH children to age-, sex-, and ethnicity-matched obese (OB) and lean (CO) controls.
  • Utilized the School Physical Activity and Nutrition Survey to assess lifestyle factors.
  • Collected blood samples for further analysis (details not specified in abstract).

Main Results:

  • Children with NASH showed significantly lower fruit intake and physical activity levels compared to both OB and CO groups.
  • A higher percentage of NASH children reported reading nutrition labels and perceived their diet as 'less healthy'.
  • Sedentary behavior was strongly associated with advanced fibrosis (grade 2-3) in NASH patients.

Conclusions:

  • Pediatric NASH is associated with detrimental lifestyle behaviors, including reduced physical activity and fruit consumption.
  • Increased sedentary behavior correlates with more severe liver fibrosis in children with NASH.
  • Further research is warranted to explore the therapeutic potential of modifying these behaviors for NASH treatment.
Abstract

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...